CHIKARA OKAFOR: Open Payments
NPI 1073098950 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 4 payments from 4 companies in 2025. Trend: 2023 $142 · 2024 $120 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 1 | $56 |
| Otsuka America Pharmaceutical, Inc. | 1 | $46 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: REZDIFFRA, INVEGA SUSTENNA, REXULTI.
Industry payments across NJ — which companies pay providers there.
